The global spectrometry market is valued at $20.41 billion in 2024 and is expected to grow to $22.03 billion by 2025. By 2034, it is projected to nearly double, reaching approximately $43.93 billion, with a robust compound annual growth rate (CAGR) of 7.97% over the forecast period. This growth is fueled by expanding research and development activities, increased investments and partnerships, and the rising prevalence of chronic diseases driving demand for advanced diagnostic tools.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5359
Spectrometry Market: Unveiling Its Potential
Spectrometry is a powerful analytical technique used to measure the interaction between light or electromagnetic radiation and matter. It allows scientists to analyze specific spectrums for studying the composition and properties of materials. Key spectrometry techniques include optical, ion-mobility, mass, Rutherford backscattering, neutron triple-axis, gamma, nuclear magnetic resonance (NMR), infrared, and Raman spectrometry. These methods are widely used to quantify optical density, absorbance, and transmittance. Spectrometers, the instruments behind these analyses, measure wavelengths, frequencies, and atomic compositions in samples.
The market is witnessing growth due to the increasing prevalence of chronic disorders, which drives demand for advanced research. Areas like drug discovery, proteomics, metabolomics, forensic analysis, and pharmaceutical studies rely heavily on spectroscopic measurements. Innovations in spectrometer technology have made these tools more efficient and user-friendly, further accelerating their adoption. Government and private funding for research and development also bolster market growth.
Notable Trends in the Spectrometry Market
- In June 2024, Thermo Fisher Scientific launched the Thermo Scientific Stellar mass spectrometer, enabling researchers to advance omics research with greater efficiency and precision through fast throughput and high sensitivity.
- Shimadzu Scientific Instruments introduced the LCMS RX series of triple quadrupole mass spectrometers during ASMS 2024 in Anaheim, California.
- In October 2023, Revvity, Inc. collaborated with SCIEX to enhance SCIEX’s mass spectrometry technology within Revvity’s newborn screening solutions.
How AI is Transforming the Spectrometry Market
Artificial intelligence (AI) is making significant inroads into healthcare, and its potential in spectrometry is increasingly being explored. AI, particularly through machine learning (ML), can analyze data from spectrometers with remarkable efficiency, reducing manual errors and improving the accuracy of results. These technologies address challenges like high signal-to-noise ratios, batch measurement inconsistencies, and missing data.
ML models can generate predicted spectra closely aligned with experimental results, enabling precise and reliable analysis. AI also facilitates the simultaneous processing of large-scale complex data, which is crucial in high-throughput research environments.
Despite these advantages, the integration of AI in spectrometry is still in its early stages. Successful implementation requires expertise across multiple disciplines, which can slow adoption. However, as these barriers are addressed, AI is expected to significantly enhance spectrometry’s capabilities and efficiency.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/spectrometry-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5359
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
